Public Health Agency of Canada
Symbol of the Government of Canada

Français

Publicly funded Immunization Programs in Canada - Routine Schedule for Infants and Children (including special programs and catch-up programs)

Province/
Territory
DTaP-IPV-Hib DTaP-IPV Td, Tdap
or
Td-IPV
HB MMR Var Men-C Menactra-(Groups A, C, Y, W-135 conjugate) Pneu-C-7 Inf HPV
NACI recom-
mendation
2,4,6,18 mths 4-6 yrs 14-16 yrs Infancy
(3 doses)
OR
Pre-teen/teen
12 mths, 18m/4-6 yrs Children between 12 & 18 mths 2, 4, 6 mths
OR
12 mths, if not yet given
OR
14-16 yrs, if not yet given
High risk individuals 2-55 yrs of age2 2, 4, 6, 12/15 mths 6-23 mths (1-2 doses) Females 9-26 yrs (3 doses at 0, 2 and 6 months)1
BC 2,4,6,18 mths 4-6 yrs dTap, Gr 9 2,4,6 mths Gr 6 Catch- up (2 doses) 12, 18 mths 12 mths,
4-6 yr olds, and Grade 6
2,12 mths
Gr 6 catch-up
  Healthy children: 2,4,12 mths
High risk children: 2,4,6,12 mths
6-23 mths Starting in Sept 2008:
Females in Gr 6 and Gr.9 (3 doses given @ 0, 2, 6 mos)
AB 2,4,6,18 mths 4-6 yrs dTap, Gr 9 Gr. 5 12 mths, 4-6 yrs 12 mths 2, 4 and 12 months   2,4,6,18 mths 6-59 mths Starting in Sept 2008: Females in Gr 5. Gr 9 girls from 2009 to 2012
SK 2,4,6,18 mths 4-6 yrs dTap, Gr 8 Gr. 6 12, 18 mths and Gr 8 & 12 catch up 12 mths
Gr 6 catch-up
12 mths
4-6 yr and Gr 6 catch up
  2,4,6,18 mths
At risk children up to 59 mths
6-23 mths Starting in Sept 2008:
Gr 6 (3 doses @ 0,2 and 6mos) and
Females in Gr 7 for one year only
MB 2,4,6,18 mths 4-6 yrs dTap, 14-16 yrs Gr. 4 12 mths, 4-6 yrs 12 mths
4-6 yr old catch-up, Gr 4 catch-up
Gr. 4
* will be changing to 12 month of age in Jan 2009
  2,4,6,18 mths 6-23 mths Starting in Sept 2008:
Females in Gr 6.
ON 2,4,6,18 mths 4-6 yrs dTap 14-16 yrs Gr. 7 (2 doses) 12, 18 mths 15 mths 12 mths, Gr. 7 catch up and 15-19 yr catch up   2,4,6,15 mths ≥6 mths Females in Gr 8 (3 doses @ months 0, 2, and 6)
QC 2,4,6,18 mths 4-6 yrs dTap, Gr 10 and 1 dose for ≥ 7 yrs Gr. 4 12, 18 mths 12 mths
4-6 yr old catch-up, Gr 4 catch up, health professional non-immune 
12 mths   2,4,12 mths 6-23 mths Starting in Sept 2008 Grade 4 and Secondary 3rd of high school
NB 2,4,6,18 mths 4-6 yrs dTap, Gr 9
Gr 6 catch up (2006-2009)
0, 2, 6 mths 12, 18 mths 12 mths 12 mths
Gr 9 2,4,6,18 mths 6-23 mths Begins Sept 2008 for girls in Gr 7 & 8
NS 2,4,6,18 mths 4-6 yrs dTap, 14-16 yrs, Gr 7 Program on hold until 2010 12 mths, 4-6 yrs. 12 mths
1-6 yr old catch-up
12 mths ,
Gr 7 and 14-16 yr old catch-up
  2,4,6,18 mths 6-23 mths Females in Gr 7
PE 2,4,6,18 mths 4-6 yrs dTap, Gr 9 2,4,15 mths 15, 18 mths 12 mths 12 mths Gr 9 2,4,6,18 mths   Females in Grade 6 (3 doses @ 0,1-2 and 6 mths)
NL 2,4,6,18 mths 4-6 yrs dTap, Gr 9 Gr. 4 12, 18 mths 12 mths
4-6 yr old catch-up
12 mths
Gr 4 catch-up abd Gr 9 catch-up
Used in outbreak situations 2,4,6,18 mths 6-23 mths Females in Gr 6 (3 doses) and starting in Sept 2008, females in Gr 9
NT 2,4,6,18 mths 4-6 yrs dTap, Gr 9 0, 1, 6 mths 12, 18 mths, Post secondary students attending schools outside NT 12 mths Catch-up for children <5 yrs old 2 and 12 mos 
catch-up for children   < 5 yrs old
and catch-up grade 9
Post secondary students attending schools outside NT 2,4,6, 18 mths  6-23 mths  
YT 2,4,6,18 mths 4-6 yrs dTap, Gr 9 . 2,4,12 mths,  and ≤19 yrs if not previously immunized 12, 18 mths 12 mths 2, 6 mths, grade 9 catch-up; post secondary students leaving school and/or not previously vaccinated.   2,4,6,18 mths 6-23 mths Starting in March 2009, 3 doses for females in Gr 5 . For 2009 only, Gr 6 & 7
NU 2,4,6,18 mths 4-6 yrs dTap, Gr 9 0, 1, 9 mths 12, 18 mths, Gr 12 15 mths 12 mths
14-16 yr old catch-up
  2,4,6,15 mths ≥6 mths  
Original Source: Canadian Nursing Coalition on Immunization, 2004
Updated: 2008-05-13
Legend:
DTaP: Diphtheria, Tetanus, Acellular Pertussis
HB: Hepatitis B
Hib: Haemophilus Influenzae Tybe b
HPV: Human Papillomavirus
Inf: Influenza
IPV: Inactivated Polio
Men C: Meningococcal conjugate
MMR: Measles, Mumps, Rubella
Pneu-C-7: Pneumococcal conjugate
Var: Varicella
1  Recommended use:
i) The HPV vaccine is recommended for females between 9 and 13 years of age, as this is before the onset of sexual intercourse for most females in Canada, and the efficacy would be greatest.
ii) Females between the ages of 14 and 26 years would benefit from the HPV vaccine, even if they are already sexually active, as they may not yet have HPV infection and are very unlikely to have been infected with all four HPV types in the vaccine.
iii) Females between the ages of 14 and 26 years who have had previous Pap abnormalities, including cervical cancer, or have had genital warts or known HPV infection would still benefit from the HPV vaccine.2 Specific recommendations for Menactra use can be found here: http://www.phac-aspc.gc.ca/publicat/ccdr-rmtc/07vol33/acs-03/index_e.html